# Syncope Admission Criteria

Admit syncope patients when a serious condition is identified or suspected after focused evaluation. Use ECG, hemodynamics, cardiac history, troponin, and clinical impression to distinguish patients needing inpatient treatment from those appropriate for discharge or structured observation.

**Clinical question:** Which adults presenting with syncope require hospital admission, observation, or discharge after emergency department evaluation?

Updated: 2026-09-15T21:54:15.776551+00:00

## What matters in practice
- Hospital evaluation and treatment are recommended when the initial assessment identifies a serious medical condition potentially related to syncope. [2]
- Abnormal ECG, elevated troponin, known arrhythmia, extreme ED systolic blood pressure, and structural or ischemic cardiac features should shift disposition toward admission or monitored observation. [10][12][16]
- Patients with a convincing neurally mediated or orthostatic mechanism and no evidence of a cardiac cause can generally be discharged without prolonged observation or additional testing. [5][11]
- For intermediate-risk adults without an immediate indication for full admission, an ED observation protocol can substitute for routine inpatient admission while monitoring for actionable bradyarrhythmia, tachyarrhythmia, or structural disease. [14][15]
- Risk scores can support, but should not replace, clinician assessment and identification of an immediately treatable cause such as conduction disease, acute coronary syndrome, hemorrhage, pulmonary embolism, or severe valvular disease. [2][10][12][13]

## Admit when syncope is linked to a serious condition

Disposition follows cause and short-term risk, not the symptom alone.

Perform a focused initial assessment that establishes whether syncope is attributable to a serious condition requiring inpatient treatment. Hospital evaluation and treatment are recommended when such a condition is identified or is potentially relevant to the event. [2]

Admission is favored for suspected cardiac syncope because cardiac syncope carries substantially greater mortality than noncardiac syncope; reported 1-year mortality is 18% to 33% with cardiac syncope versus 3% to 4% without a cardiac cause. [13] Cardiac etiologies requiring expedited evaluation include arrhythmia, conduction disease, cardiomyopathy, valvular heart disease, ischemia, and acute thromboembolic disease. [11][12]

Do not admit solely because the cause remains unexplained if the history supports reflex or orthostatic syncope, ECG and hemodynamics are reassuring, and no serious condition is suspected. A substantial proportion of ED syncope evaluations remain etiologically unresolved, but low-risk patients with a readily identified noncardiac mechanism generally do not benefit from hospitalization. [5][12]
- Admit for a serious diagnosis made in the ED when inpatient therapy is needed, such as pacemaker implantation for clinically significant bradyarrhythmia or transfusion for gastrointestinal hemorrhage/anemia. [4][15]
- Admit when delayed evaluation could expose the patient to an adverse outcome from acute coronary syndrome, conduction disease, worrisome cardiac disease, significant valvular disease, or a familial sudden-death syndrome. [13]
- Use age as a modifier rather than an isolated admission criterion: patients older than 75 years have poorer fatal and nonfatal outcomes, compounded by multimorbidity, frailty, and injury risk. [1]

*Disposition framework after focused ED evaluation. [2][5][11][13]*

| Disposition | Findings that support this choice | Immediate next action |
| --- | --- | --- |
| Inpatient admission | Serious condition identified or suspected; acute coronary syndrome symptoms; conduction disease; worrisome cardiac history; clinical valvular disease; ischemic ECG changes, arrhythmia, prolonged QT interval, or bundle-branch block. [2][12][13] | Treat the identified disorder and use monitored evaluation for clinically important arrhythmia or structural cardiac disease. [2][15] |
| Monitored ED observation | Intermediate risk without an immediate diagnosis or a clear indication for full inpatient admission, particularly adults aged 50 years or older. [14][15] | Telemetry and targeted testing; escalate to admission if a serious event or actionable diagnosis emerges. [15] |
| ED discharge | Convincing neurally mediated or orthostatic mechanism, no suspected cardiac cause, and no serious condition identified during evaluation. [5][11] | Address reversible contributors, particularly medication-related hypotension, and provide follow-up appropriate to recurrent or unexplained events. [1][5] |

## Identify high-risk features before assigning a disposition

Use history, vital signs, ECG, and targeted laboratory testing to detect actionable risk.

Obtain a 12-lead ECG and treat it as a disposition-changing test. Acute ischemic changes, dysrhythmia, significant conduction abnormality, prolonged QT interval, and bundle-branch block are high-risk findings that support hospital-based evaluation. [12] In an older-adult cohort, an abnormal ECG independently predicted 30-day serious events. [10]

Interpret ED blood pressure at both extremes. Canadian Syncope Risk Score predictors include mean ED systolic blood pressure below 90 mm Hg or above 180 mm Hg. [16] In older patients, triage systolic blood pressure above 160 mm Hg was associated with 30-day serious events, alongside age older than 90 years, male sex, known arrhythmia, abnormal ECG, and elevated troponin I. [10]

Order troponin when clinical evaluation raises concern for ischemia or cardiac risk, then incorporate an elevated result into disposition rather than treating it as an isolated screening abnormality. Elevated troponin is a Canadian Syncope Risk Score predictor and independently predicted 30-day serious events in older adults. [10][16] Assess dyspnea, anemia or bleeding, heart failure, and symptoms of acute coronary syndrome because each can reveal a nonarrhythmic cause that requires admission and treatment. [6][12][13]
- Known heart disease, history of arrhythmia, heart failure, ventricular arrhythmia, or physical findings of valvular disease increase concern for cardiac syncope. [10][12][13]
- Family history of sudden death is a medium-risk feature that should lower the threshold for monitored cardiac evaluation, particularly with abnormal ECG findings or unexplained syncope. [12]
- Near-syncope was associated with lower 30-day event risk than true syncope in one older-adult cohort, but should not override abnormal ECG, troponin, hemodynamics, or a concerning cardiac history. [10]

*High-risk variables with explicit thresholds reported in syncope cohorts and risk models. [6][10][16]*

| Variable | Threshold or feature | Disposition implication |
| --- | --- | --- |
| Systolic blood pressure | Mean ED systolic pressure below 90 mm Hg or above 180 mm Hg. [16] | Raises short-term serious-event risk; investigate the hemodynamic cause and use monitored care or admission when serious disease is suspected. [16] |
| ECG | QRS duration 130 ms or greater, QRS axis below 30° or above 110°, or corrected QT interval above 480 ms are Canadian Syncope Risk Score predictors. [16] | Treat as cardiac-risk markers and integrate with history, troponin, and final ED diagnostic impression. [16] |
| ECG or clinical rule findings | Abnormal ECG, shortness of breath, hematocrit below 30%, systolic blood pressure below 90 mm Hg, or heart-failure history. [6] | Any feature identifies higher short-term risk in the San Francisco Syncope Rule; investigate the corresponding cardiac, pulmonary, hemorrhagic, or hemodynamic disorder. [6] |
| Troponin | Elevated troponin. [10][16] | Raises concern for a serious cardiac process and should influence disposition with the ECG and clinical presentation. [10][16] |

## Use the suspected mechanism to select admission, observation, or discharge

A named mechanism is more useful than undifferentiated “unexplained syncope.”

For suspected arrhythmic syncope, admit or observe with cardiac monitoring when the ECG is abnormal, there is known arrhythmia or structural heart disease, or the event remains unexplained with a concerning cardiac history. Arrhythmia was the most common serious event detected after an initially unrevealing ED evaluation in older adults. [10] During syncope observation studies, clinically significant events included ventricular arrhythmia, Mobitz II or complete heart block, sick sinus syndrome, sinus pause longer than 3 seconds, symptomatic supraventricular tachycardia above 100 beats/min, and symptomatic bradycardia below 60 beats/min. [15]

For reflex or orthostatic syncope, discharge is reasonable when the mechanism is clinically apparent and there is no cardiac concern. Review medications because diuretics, vasodilators, venodilators, negative chronotropes, and sedatives are implicated in medication-related syncope, particularly among older adults; adjust these agents under close supervision when medication effect is plausible. [1][5][11]

For secondary serious causes, admit according to the identified disease rather than a generic syncope pathway. Dyspnea, hematocrit below 30%, systolic pressure below 90 mm Hg, and heart-failure history are high-risk features in the San Francisco Syncope Rule and should direct evaluation toward pulmonary, hemorrhagic, hemodynamic, or cardiac disease. [6] Serious-event definitions in syncope research include myocardial infarction, pulmonary embolism, aortic dissection, structural heart disease, pulmonary hypertension, and serious arrhythmia. [17]
- Obtain echocardiography selectively when history, examination, or ECG suggests structural cardiac disease; echocardiography was requested substantially more often among patients classified with cardiac versus neurally mediated or orthostatic syncope. [11]
- Do not use a normal-appearing patient after recovery as reassurance when high-risk ECG, cardiac-history, troponin, or hemodynamic findings persist; serious arrhythmia may be missed at the index evaluation. [10][13]
- Consider the injury and functional consequences of recurrence in older adults: recurrent syncope can precipitate trauma, nursing-home placement, and loss of independence, factors that may affect the safety of discharge even when a malignant rhythm is not established. [1]

*Etiology-based disposition after ED assessment. [1][5][10][11][15]*

| Suspected mechanism | Discriminating findings | Disposition and next step |
| --- | --- | --- |
| Arrhythmic or conduction-related syncope | Abnormal ECG, known arrhythmia, structural heart disease, or monitored detection of clinically important bradyarrhythmia or tachyarrhythmia. [10][12][15] | Admit or use monitored observation; arrange definitive cardiac intervention when an actionable rhythm disorder is identified. [4][15] |
| Structural or ischemic cardiac disease | Heart-failure history or signs, valvular disease, acute coronary syndrome symptoms, ischemic ECG changes, or elevated troponin. [6][10][12][13] | Admit for disease-directed testing and treatment; use echocardiography when structural disease is suspected. [11] |
| Neurally mediated or orthostatic syncope | Clinically apparent mechanism without suspected cardiac cause or other serious disorder. [5][11] | Discharge without prolonged observation; review hypotensive or rate-slowing medications when relevant. [1][5] |
| Hemorrhagic, pulmonary, or vascular cause | Hematocrit below 30%, dyspnea, hypotension, or evidence suggesting pulmonary embolism, aortic dissection, or other serious disease. [6][17] | Admit and pursue disease-specific evaluation and treatment. [2][17] |

## When ED observation can replace routine admission

Observation is a disposition pathway for selected patients, not a substitute for treating an identified emergency.

Consider a structured ED observation protocol for intermediate-risk adults, particularly those aged 50 years or older, when initial evaluation does not identify a condition requiring inpatient treatment. A randomized trial compared an ED observation syncope protocol with routine inpatient admission in this population. [14][15] Observation should include monitoring directed at detecting the rhythm and structural diagnoses that would change management. [15]

Escalate from observation to inpatient admission when telemetry or targeted testing identifies ventricular arrhythmia, high-grade atrioventricular block, sinus node dysfunction, significant pauses, symptomatic tachyarrhythmia, symptomatic bradycardia, or another serious diagnosis requiring treatment. [15] Patients classified as having cardiac syncope were more likely than those with neurally mediated or orthostatic syncope to require observation of at least 12 hours, pacemaker implantation, and hospitalization. [11]

Use clinical risk scores to organize variables, not to disregard clinician concern. Canadian Syncope Risk Score components include blood-pressure extremes, vasovagal predisposition, heart disease, final ED diagnosis, elevated troponin, QRS duration at least 130 ms, marked QRS-axis abnormality, and corrected QT interval above 480 ms. [16] In a propensity-matched cohort, admission produced little incremental in-hospital detection of serious outcomes among very-low- and low-risk groups, whereas the difference was more pronounced in medium-, high-, and very-high-risk groups. [16]
- A high-risk older-adult profile includes age above 90 years, male sex, known arrhythmia, triage systolic pressure above 160 mm Hg, abnormal ECG, and abnormal troponin I. [10]
- Intermediate-risk disposition should account for whether the needed diagnostic test or intervention can be completed safely within an observation setting. [2][15]
- When a serious disease is already evident, bypass risk scoring and admit for treatment of that condition. [2][4]

*Practical role of risk stratification in selecting observation versus admission. [10][15][16]*

| Clinical state | Evidence-based risk signal | Operational choice |
| --- | --- | --- |
| Very low or low risk | Admission had little incremental detection of serious adverse events compared with discharge in a matched cohort. [16] | Discharge if a benign mechanism is supported and no serious condition is suspected. [5][16] |
| Intermediate risk | No immediate serious diagnosis but persistent uncertainty after initial evaluation. [14][15] | Use ED observation with monitoring and targeted testing rather than routine inpatient admission when appropriate. [14][15] |
| Medium, high, or very high risk | Admission was associated with more in-hospital detection of serious adverse events than discharge in a matched cohort. [16] | Admit or continue monitored evaluation, directed by the suspected cardiac or noncardiac cause. [2][16] |

## Lower the threshold for monitored care in frail older adults

Age does not mandate admission, but it changes the consequences of diagnostic error and recurrent events.

Older patients have greater hospitalization and death risk after syncope, with risk compounded by multimorbidity, frailty, and more consequential fall-related injury. [1] Among patients older than 80 years presenting to the ED with syncope, 58% were admitted in national survey data. [1] Use this context to assess whether discharge is functionally safe, especially after an injurious event or when recurrent syncope threatens independence. [1]

Medication review is a required part of the evaluation in older adults. Diuretics, vasodilators, venodilators, negative chronotropes, and sedatives have been implicated in syncope; medication-related syncope appears more prevalent in older patients. [1] If medications are a plausible contributor and serious cardiac disease is not suspected, adjust the responsible regimen with close follow-up rather than defaulting to an extensive inpatient diagnostic admission. [1][5]

Do not attribute syncope to medications or orthostasis without first addressing competing high-risk findings. In older cohorts, known arrhythmia, abnormal ECG, and elevated troponin I predicted 30-day serious events, and arrhythmia was the most common serious diagnosis made after the ED evaluation. [10]
- Treat age above 90 years as a risk marker when combined with abnormal ECG, troponin, known arrhythmia, or concerning vital signs. [10]
- Consider observation or admission when recurrent syncope creates unacceptable trauma or functional risk despite a noncardiac mechanism. [1]
- When medication adjustment is undertaken, supervise closely because changing one agent may worsen preexisting supine hypertension or other comorbid conditions. [1]

*Older-adult factors that modify syncope disposition. [1][10]*

| Finding | Why it changes disposition | Action |
| --- | --- | --- |
| Frailty, recurrent events, or injury | Syncope-related falls and recurrent events can lead to trauma, institutionalization, and loss of independence. [1] | Incorporate home safety and functional consequences into discharge planning; observe or admit if recurrence risk cannot be managed safely. [1] |
| Potential medication contribution | Diuretics, vasodilators, venodilators, negative chronotropes, and sedatives are implicated in syncope. [1] | Review and adjust likely contributors with close supervision after excluding serious cardiac disease. [1][5] |
| Abnormal ECG or troponin | Both predicted 30-day serious events in older adults. [10] | Use monitored evaluation and investigate cardiac causes rather than attributing symptoms to age or polypharmacy. [10] |

## References
1. 2017 ACC/AHA/HRS Guideline for the Evaluation and ... - JACC — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2017.03.003
2. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management ... — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2017.03.002
3. ACC/AHA/HRS Versus ESC Guidelines for the Diagnosis ... - JACC — www.jacc.org — https://www.jacc.org/doi/10.1016/j.jacc.2019.09.012
4. Risk Stratification of Older Adults Who Present to the Emergency Department With Syncope: The FAINT Score — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S0196064419311138
5. Syncope risk stratification in the ED - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S1566070214000587
6. Syncope as an Emergency Department Presentation of Pulmonary Embolism — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S073646799700228X
7. Syncope in the Emergency Department: Should We Be Using the Canadian Syncope Risk Score? - Annals of Emergency Medicine — www.annemergmed.com — https://www.annemergmed.com/article/S0196-0644(23)00388-8/fulltext
8. ESC 365 - Management of syncope in the emergency department based on risk stratification — esc365.escardio.org — https://esc365.escardio.org/presentation/166812
9. Measurement of Observer Agreement | Radiology - RSNA Journals — pubs.rsna.org — https://pubs.rsna.org/doi/10.1148/radiol.2282011860
10. Predictors of 30-Day Serious Events in Older Patients with Syncope — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC2788122
11. Cardiac findings and observation duration in patients with syncope in the emergency department: a cohort study — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC13085609
12. Risk stratification of adult emergency department syncope patients to predict short-term serious outcomes after discharge (RiSEDS) study — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC4003802
13. PREDICTING ADVERSE OUTCOMES IN SYNCOPE - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC2276584
14. Randomized Clinical Trial of an Emergency Department ... — www.annemergmed.com — https://www.annemergmed.com/article/S0196-0644(13)01548-5/abstract
15. Randomized Clinical Trial of an Emergency Department Observation Syncope Protocol vs. Routine Inpatient Admission — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC4019722
16. Benefit of hospital admission for detecting serious adverse events among emergency department patients with syncope: a propensity-score–matched analysis of a multicentre prospective cohort - PMC — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC7588246
17. Development of a Novel Emergency Department Quality Measure to Reduce Very Low-Risk Syncope Hospitalizations — pmc.ncbi.nlm.nih.gov — https://pmc.ncbi.nlm.nih.gov/articles/PMC9117517

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.